SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1.
Journal: Acta pharmaceutica Sinica. B
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Du L, Wang M, Liu X, et al. (2026). "SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1.". Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.07.042